Cleared Traditional

K031367 - DUOPATH VEROTOXINS GLISA TEST

K031367 is an FDA 510(k) clearance for DUOPATH VEROTOXINS GLISA TEST, manufactured by Emd Chemicals, Inc.. The device is a Class 1 Microbiology device with product code GNA cleared through the Traditional 510(k) pathway after a 268-day FDA review.

K031367 · Emd Chemicals, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2004
Decision
268d
Days
Class 1
Risk

K031367 is an FDA 510(k) clearance for the DUOPATH VEROTOXINS GLISA TEST. Classified as Antisera, All Types, Escherichia Coli (product code GNA), Class I - General Controls.

Submitted by Emd Chemicals, Inc. (Gibbstown, US). The FDA issued a Cleared decision on January 23, 2004 after a review of 268 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3255 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Emd Chemicals, Inc. devices

FDA 510(k) Submission Details - K031367

510(k) Number K031367 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 2003
Decision Date January 23, 2004
Days to Decision 268 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
166d slower than avg
Panel avg: 102d · This submission: 268d
Pathway characteristics
Predicate-based equivalence.

GNA Device Classification - Class 1, General Controls

Product Code GNA Antisera, All Types, Escherichia Coli
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3255
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GNA Antisera, All Types, Escherichia Coli

All 10
Devices cleared under the same product code (GNA) and FDA review panel - the closest regulatory comparables to K031367.
DRYSPOT E.COLI 0157 KIT
K993401 · Oxoid , Ltd. · Feb 2000
VTEC-RPLA SEIKEN
K981734 · Denka Seiken'S · Sep 1998
WELLCOLEX E-COLI OI57 ZC60
K962028 · Murex Diagnostics, Inc. · Nov 1996
PREMIER EHEC
K953362 · Meridian Diagnostics, Inc. · Nov 1995
PREMIER EHEC
K950167 · Meridian Diagnostics, Inc. · Apr 1995
RIM E.COLI 0157:H7 LATEX TEST
K933457 · Remel Co. · Apr 1994